CN104764787A - 快速测定蛋白混合物中的各组分含量的毛细管等电聚焦方法 - Google Patents
快速测定蛋白混合物中的各组分含量的毛细管等电聚焦方法 Download PDFInfo
- Publication number
- CN104764787A CN104764787A CN201310624166.6A CN201310624166A CN104764787A CN 104764787 A CN104764787 A CN 104764787A CN 201310624166 A CN201310624166 A CN 201310624166A CN 104764787 A CN104764787 A CN 104764787A
- Authority
- CN
- China
- Prior art keywords
- analyzed
- isoelectric point
- isoelectric focusing
- protein
- protein mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 48
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 37
- 238000000533 capillary isoelectric focusing Methods 0.000 title claims abstract description 27
- 239000004615 ingredient Substances 0.000 title abstract 5
- 238000001155 isoelectric focusing Methods 0.000 claims abstract description 19
- 235000018102 proteins Nutrition 0.000 claims description 40
- 239000003814 drug Substances 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 14
- 235000004252 protein component Nutrition 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 230000008033 biological extinction Effects 0.000 claims description 5
- 239000004202 carbamide Substances 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 5
- 229920000609 methyl cellulose Polymers 0.000 claims description 5
- 239000001923 methylcellulose Substances 0.000 claims description 5
- 235000010981 methylcellulose Nutrition 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 238000010606 normalization Methods 0.000 claims description 4
- 102100030497 Cytochrome c Human genes 0.000 claims description 3
- 108010075031 Cytochromes c Proteins 0.000 claims description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 3
- 108010015776 Glucose oxidase Proteins 0.000 claims description 3
- 239000004366 Glucose oxidase Substances 0.000 claims description 3
- 102000008192 Lactoglobulins Human genes 0.000 claims description 3
- 108010060630 Lactoglobulins Proteins 0.000 claims description 3
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 claims description 3
- 102000005891 Pancreatic ribonuclease Human genes 0.000 claims description 3
- 101710162629 Trypsin inhibitor Proteins 0.000 claims description 3
- 229940122618 Trypsin inhibitor Drugs 0.000 claims description 3
- 102000018690 Trypsinogen Human genes 0.000 claims description 3
- 108010027252 Trypsinogen Proteins 0.000 claims description 3
- 238000005251 capillar electrophoresis Methods 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229940116332 glucose oxidase Drugs 0.000 claims description 3
- 235000019420 glucose oxidase Nutrition 0.000 claims description 3
- 108010034897 lentil lectin Proteins 0.000 claims description 3
- 239000002753 trypsin inhibitor Substances 0.000 claims description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 2
- 235000013877 carbamide Nutrition 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 238000004458 analytical method Methods 0.000 abstract description 12
- 238000005516 engineering process Methods 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000003908 quality control method Methods 0.000 abstract description 5
- 238000012545 processing Methods 0.000 abstract description 2
- 238000001228 spectrum Methods 0.000 abstract 5
- 239000011259 mixed solution Substances 0.000 abstract 2
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 29
- 238000004255 ion exchange chromatography Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 230000010354 integration Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 101100476210 Caenorhabditis elegans rnt-1 gene Proteins 0.000 description 3
- 102100025518 Carbonic anhydrase 1 Human genes 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108010033547 Carbonic Anhydrase I Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000005277 cation exchange chromatography Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102100030856 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010047320 Pepsinogen A Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000001818 capillary gel electrophoresis Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 229940125645 monoclonal antibody drug Drugs 0.000 description 1
- 239000012514 monoclonal antibody product Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
时间 | 事项 |
0 | INT-(积分关) |
6.5 | INT+(积分开) |
9.3 | INT-(积分关) |
6.5 | HORZ+(水平基线) |
6.5 | COM+(共用基线) |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310624166.6A CN104764787B (zh) | 2013-11-28 | 2013-11-28 | 快速测定蛋白混合物中的各组分含量的毛细管等电聚焦方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310624166.6A CN104764787B (zh) | 2013-11-28 | 2013-11-28 | 快速测定蛋白混合物中的各组分含量的毛细管等电聚焦方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104764787A true CN104764787A (zh) | 2015-07-08 |
CN104764787B CN104764787B (zh) | 2018-03-06 |
Family
ID=53646750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310624166.6A Active CN104764787B (zh) | 2013-11-28 | 2013-11-28 | 快速测定蛋白混合物中的各组分含量的毛细管等电聚焦方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104764787B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106932459A (zh) * | 2015-12-31 | 2017-07-07 | 深圳翰宇药业股份有限公司 | 一种多肽聚合物毛细管等电聚焦分析方法 |
CN109675344A (zh) * | 2018-12-26 | 2019-04-26 | 上海交通大学 | 固化pH梯度的毛细管等电聚焦亲水性整体柱及制备方法 |
CN111220676A (zh) * | 2019-11-13 | 2020-06-02 | 上海药明生物技术有限公司 | 利用毛细管电泳技术检测含聚乙二醇的蛋白质样品纯度的方法 |
CN111505094A (zh) * | 2020-04-28 | 2020-08-07 | 上海交通大学 | 一种基于等电聚焦电泳的食品饲料种属溯源鉴定方法 |
CN115541686A (zh) * | 2022-11-25 | 2022-12-30 | 黑龙江飞鹤乳业有限公司 | 乳制品鉴别方法 |
CN117783517A (zh) * | 2024-02-23 | 2024-03-29 | 北京生物制品研究所有限责任公司 | 一种表征百日咳毒素成像毛细管等电聚焦电泳方法及应用 |
-
2013
- 2013-11-28 CN CN201310624166.6A patent/CN104764787B/zh active Active
Non-Patent Citations (4)
Title |
---|
BRYAN R. FONSLOW ET AL: "Native Capillary Isoelectric Focusing for the Separation of Protein Complex Isoforms and Subcomplexes", 《ANALYTICAL CHEMISTRY》 * |
MING L. SHIH AND WILLIAM D. KORTE: "Analysis of Hemoglobin Derivatives by Capillary Isoelectric Focusing and Its Application in the Antidotal Research of Cyanide Poisoning", 《ANALYTICAL BIOCHEMISTRY》 * |
张嵬 等: "毛细管凝胶电泳法测定血浆中的癌泰得", 《色谱》 * |
王丽、周勇、王军志: "成像毛细管等电聚焦电泳分析糖蛋白类生物技术药物", 《中国生物制品学杂志》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106932459A (zh) * | 2015-12-31 | 2017-07-07 | 深圳翰宇药业股份有限公司 | 一种多肽聚合物毛细管等电聚焦分析方法 |
CN109675344A (zh) * | 2018-12-26 | 2019-04-26 | 上海交通大学 | 固化pH梯度的毛细管等电聚焦亲水性整体柱及制备方法 |
CN111220676A (zh) * | 2019-11-13 | 2020-06-02 | 上海药明生物技术有限公司 | 利用毛细管电泳技术检测含聚乙二醇的蛋白质样品纯度的方法 |
CN111220676B (zh) * | 2019-11-13 | 2022-11-29 | 上海药明生物技术有限公司 | 利用毛细管电泳技术检测含聚乙二醇的蛋白质样品纯度的方法 |
CN111505094A (zh) * | 2020-04-28 | 2020-08-07 | 上海交通大学 | 一种基于等电聚焦电泳的食品饲料种属溯源鉴定方法 |
CN115541686A (zh) * | 2022-11-25 | 2022-12-30 | 黑龙江飞鹤乳业有限公司 | 乳制品鉴别方法 |
CN117783517A (zh) * | 2024-02-23 | 2024-03-29 | 北京生物制品研究所有限责任公司 | 一种表征百日咳毒素成像毛细管等电聚焦电泳方法及应用 |
CN117783517B (zh) * | 2024-02-23 | 2024-04-19 | 北京生物制品研究所有限责任公司 | 一种表征百日咳毒素成像毛细管等电聚焦电泳方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104764787B (zh) | 2018-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Füssl et al. | Comparative elucidation of cetuximab heterogeneity on the intact protein level by cation exchange chromatography and capillary electrophoresis coupled to mass spectrometry | |
CN104764787A (zh) | 快速测定蛋白混合物中的各组分含量的毛细管等电聚焦方法 | |
Füssl et al. | Comprehensive characterisation of the heterogeneity of adalimumab via charge variant analysis hyphenated on-line to native high resolution Orbitrap mass spectrometry | |
Fekete et al. | Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals | |
Tamizi et al. | The potential of the capillary electrophoresis techniques for quality control of biopharmaceuticals—a review | |
Wang et al. | High resolution capillary isoelectric focusing mass spectrometry analysis of peptides, proteins, and monoclonal antibodies with a flow-through microvial interface | |
Gahoual et al. | Full antibody primary structure and microvariant characterization in a single injection using transient isotachophoresis and sheathless capillary electrophoresis–tandem mass spectrometry | |
Staub et al. | Intact protein analysis in the biopharmaceutical field | |
Dai et al. | A middle-up approach with online capillary isoelectric focusing/mass spectrometry for in-depth characterization of Cetuximab charge heterogeneity | |
Štěpánová et al. | Applications of capillary electromigration methods for separation and analysis of proteins (2017–mid 2021)–a review | |
Atmanene et al. | Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS | |
US9645156B2 (en) | Method for determining glycosylation and terminal modification of samples during protein purification process | |
Skinner et al. | Native GELFrEE: a new separation technique for biomolecular assemblies | |
WO2013181585A2 (en) | Methods related to adalimumab | |
Wu et al. | Imaged capillary isoelectric focusing: applications in the pharmaceutical industry and recent innovations of the technology | |
WO2013181586A2 (en) | Methods related to bevacizumab | |
Miao et al. | Physicochemical and biological characterization of the proposed biosimilar tocilizumab | |
Huang et al. | Automatic disulfide bond assignment using a1 ion screening by mass spectrometry for structural characterization of protein pharmaceuticals | |
Pritchard et al. | The role of ion mobility spectrometry–mass spectrometry in the analysis of protein reference standards | |
Anicetti et al. | Analytical considerations in the development of protein purification processes | |
Hassan et al. | Evaluation of the pattern and kinetics of degradation of adalimumab using a stability‐indicating orthogonal testing protocol | |
RU2670965C1 (ru) | Способ измерения количества полисорбата-80 с применением щелочного гидролиза образца с последующей вэжх | |
Huang et al. | Targeted quantification of proteoforms in Complex samples by proteoform reaction monitoring | |
US11221287B2 (en) | Methods of measuring structural and functional changes of a biomolecular composition | |
Rhodes et al. | Determination of protein purity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 214092, Wuxi, Jiangsu province Binhu District Ma Shan Mei Liang West Road, No. 88 Applicant after: WUXI APPTEC BIOPHARMACEUTICALS CO., LTD. Applicant after: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant after: Suzhou medicine bright Kant's new drug development limited company Address before: 214092, Wuxi, Jiangsu province Binhu District Ma Shan Mei Liang West Road, No. 88 Applicant before: Wuxi AppTec Biological Technology Co., Ltd. Applicant before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Suzhou medicine bright Kant's new drug development limited company |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: WUXI APPTEC CO.,LTD. TO: WUXI YAOMING KANGDE BIO-TECHNOLOGY CO., LTD. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180122 Address after: 214092, Wuxi, Jiangsu province Binhu District Ma Shan Mei Liang West Road, No. 88 Applicant after: WUXI APPTEC BIOPHARMACEUTICALS CO., LTD. Applicant after: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Applicant after: SUZHOU YAOMING KANGDE INSPECTION TESTING CO., LTD. Address before: 214092, Wuxi, Jiangsu province Binhu District Ma Shan Mei Liang West Road, No. 88 Applicant before: WUXI APPTEC BIOPHARMACEUTICALS CO., LTD. Applicant before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Suzhou medicine bright Kant's new drug development limited company |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 214092 No. 88, Mashan Meiliang West Road, Binhu District, Wuxi City, Jiangsu Province Co-patentee after: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Patentee after: Wuxi Yaoming Biotechnology Co., Ltd. Co-patentee after: SUZHOU YAOMING KANGDE INSPECTION TESTING CO., LTD. Address before: 214092 No. 88, Mashan Meiliang West Road, Binhu District, Wuxi City, Jiangsu Province Co-patentee before: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Patentee before: WUXI APPTEC BIOPHARMACEUTICALS CO., LTD. Co-patentee before: SUZHOU YAOMING KANGDE INSPECTION TESTING CO., LTD. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 214092 No. 88, Mashan Meiliang West Road, Binhu District, Wuxi City, Jiangsu Province Co-patentee after: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Patentee after: Wuxi Yaoming Biotechnology Co., Ltd. Co-patentee after: Suzhou Pharmacopoeia Testing and Inspection Co., Ltd. Address before: 214092 No. 88, Mashan Meiliang West Road, Binhu District, Wuxi City, Jiangsu Province Co-patentee before: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Patentee before: Wuxi Yaoming Biotechnology Co., Ltd. Co-patentee before: SUZHOU YAOMING KANGDE INSPECTION TESTING CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |